![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
World Heart Corp. (MM) | NASDAQ:WHRT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.28 | 0 | 00:00:00 |
World Heart Corp. (WHRT) has paused enrollment in a study of its Levacor heart pump, pending regulatory approval of refinements to the device.
The pump uses magnetic levitation to suspend the spinning impeller, its only moving part, where others use blood or mechanical bearings. The company says that's expected to provide improved blood compatibility. World Heart has been unprofitable as it is focused on development of the device.
The company said Wednesday design modifications will be "technically ready in the next two to three months," but the timeline for their implementation depends on approval by the U.S. Food and Drug Administration, the timing of which is uncertain.
Shares closed Tuesday at $1.86 and were halted premarket on the news.
-By Matt Jarzemsky, Dow Jones Newswires; 212-416-2240; matthew.jarzemsky@dowjones.com
1 Year World Heart Chart |
1 Month World Heart Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions